News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Epstein David R
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| Epstein David R (CEO) has filed a Form 4 on Seagen Inc.|
Txns:
| Granted 39,650 shares
@ $0 |
|
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Epstein David R (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Exercised 2,053 restricted stock units
@ $0
Exercised 2,874 restricted stock units
@ $0 |
|
| 06/13/2022 |
4
| Epstein David R (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.02, valued at
$40.4k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Epstein David R (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Granted 47,059 shares
@ $0 |
|
| 06/01/2022 |
4
| Epstein David R (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Exercised 2,052 restricted stock units
@ $0
Exercised 2,873 restricted stock units
@ $0 |
|
| 05/31/2022 |
4
| Epstein David R (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Bought 17,123 shares
@ $1.46, valued at
$25k
|
|
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2022 |
4
| Epstein David R (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Bought 30,000 shares
@ $1.4443, valued at
$43.3k
|
|
| 04/01/2022 |
4
| Epstein David R (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Exercised 2,052 restricted stock units
@ $0
Exercised 2,874 restricted stock units
@ $0 |
|
| 03/21/2022 |
4
| Epstein David R (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.51, valued at
$125.5k
Exercised 1,535 restricted stock units
@ $0 |
|
| 03/18/2022 |
4
| Epstein David R (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Bought 26,178 shares
@ $1.91, valued at
$50k
|
|
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Epstein David R (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Exercised 1,534 restricted stock units
@ $0 |
|
| 01/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2022 |
4
| Epstein David R (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Exercised 1,535 restricted stock units
@ $0 |
|
| 01/03/2022 |
4
| Epstein David R (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Exercised 2,052 restricted stock units
@ $0
Exercised 2,874 restricted stock units
@ $0 |
|
| 12/20/2021 |
4
| Epstein David R (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Exercised 1,535 restricted stock units
@ $0 |
|
| 12/01/2021 |
4
| Epstein David R (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Exercised 2,053 restricted stock units
@ $0
Exercised 2,873 restricted stock units
@ $0 |
|
| 11/22/2021 |
4
| Epstein David R (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Exercised 1,534 restricted stock units
@ $0 |
|
| 11/01/2021 |
4
| Epstein David R (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Exercised 2,052 restricted stock units
@ $0
Exercised 2,873 restricted stock units
@ $0 |
|
| 10/19/2021 |
4
| Epstein David R (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Exercised 1,535 restricted stock units
@ $0 |
|
| 10/01/2021 |
4
| Epstein David R (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Exercised 2,053 restricted stock units
@ $0
Exercised 2,874 restricted stock units
@ $0 |
|
| 09/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2021 |
4
| Epstein David R (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Exercised 1,534 restricted stock units
@ $0 |
|
| 07/20/2021 |
4
| Epstein David R (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Exercised 1,535 restricted stock units
@ $0 |
|
| 07/02/2021 |
4
| Epstein David R (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 24,629 restricted stock units
@ $0
Granted 34,480 restricted stock units
@ $0 |
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Epstein David R (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 27,919 options to buy
@ $23.25, valued at
$649.1k
|
|
|
|
|